“The rating on Northwell reflects its strong enterprise profile, which is anchored by its leading market position in a sizable and diverse service area, coupled with a good financial profile … [and] stable, albeit modest, operational performance in the past several years, with expectations for continued slightly positive operations in fiscal 2016,” said S&P analyst Stephen Infranco.
The outlook is stable, reflecting S&P’s view of Northwell’s dominant market position and expansive footprint in the New York metropolitan and Long Island service areas.
More articles on healthcare finance:
Moody’s revises University of Alabama Hospital’s outlook to positive
Moody’s assigns ‘A3’ rating to Northwell Health’s bonds
Spending on outpatient centers ticks up 9.2% in Q2
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
